Knowledge Check: Sarcopenic Obesity, ERABS, Foundayo®, Phys Exam
Knowledge checks will be available every fifth blog and consist of a checklist of objectives and questions based on the prior blog posts. In addition,…
Archives: Content
Clues to Deficiency: Nutrition-Associated Physical Exam Findings
Physical exam findings can be the first clue to an associated nutritional deficiency. The rarer and more obscure the association, the more likely it may…
Orforglipron: The New Oral Nonpeptide GLP-1 Receptor Agonist
Orforglipron, sold under the brand name Foundayo®, is the most recent oral GLP-1 receptor agonist to gain FDA approval. Having the differentiating feature of being…
Enhanced Recovery After Bariatric Surgery: Improving Outcomes
Protocols focused on improving patient outcomes throughout the perioperative period have been utilized for decades, with formal enhanced recovery protocols first introduced in colorectal surgery…
The Skinny on Sarcopenic Obesity
Sarcopenia refers to a loss of skeletal muscle mass accompanied by decreased muscle strength and/or physical performance. In some patients, the loss of muscle mass…
Knowledge Check: GDM, Liraglutide, Lipodystrophy, & Special Pops
Knowledge checks will be available every fifth blog and consist of a checklist of objectives and questions based on the prior blog posts. In addition,…
Special Populations: Achondroplasia, Down & Turner Syndromes
Several conditions are classified as special populations in the ABOM content outline because they are associated with an increased risk of early metabolic complications and…
Lipodystrophies: Diagnosis, Treatment, and Metabolic Consequences
Lipodystrophy syndromes are a rare group of heterogeneous disorders characterized by a lack of adipose tissue, which may seem counterintuitive to be included within the…
Step by Step Guide on How to Use the Book Series & Question Bank
One of the most common questions I receive from those who purchase my study materials is, “Where do I begin?” While everyone has their own…
The First and Last: Liraglutide (Saxenda®)
Liraglutide (Saxenda®) was the first GLP-1 receptor agonist (RA) medication approved for weight management in 2014, previously only being approved for type 2 diabetes. Although…
Gestational Diabetes: Not Sugarcoated
The global prevalence of gestational diabetes mellitus (GDM) is about 17%, although closer to the 7-10% range specifically in the United States. GDM is associated…
Short and Sweet: Growth Hormone Deficiency Essentials
Growth hormone deficiency (GHD) is included in the ABOM test content blueprint, specifically requiring the knowledge to identify signs and symptoms of…
Knowledge Check: Air Displacement, AACE Guidelines, and MTC
Knowledge checks will be available every fifth blog and consist of a checklist of objectives and questions based on the prior blog posts. In addition,…
Inside Out: Endoscopic Guidelines and Recommendations
The increased incidence and health burden of obesity supports expanded treatment options, as over 1 billion people worldwide are expected to meet obes…
Motivational Interview Walkthrough
Motivational interviewing is often one of the more challenging areas of obesity medicine because of its somewhat subjective nature. Many questions hav…
